Furthermore, we discovered that insulin or IGF-1 binds to specific receptors on tumor cell membranes to regulate tumor growth and glucose metabolism by activating the PI3K/AKT/mTOR pathway in EC, meanwhile metformin can reduce plasma IGF-1 concentration thereby exerting anticancer activity 119. Here, MTOR is linked to neoplasm.